xCella Biosciences

XCella Biosciences is an antibody discovery company based on scientific research from Stanford University and MIT. xCella's xPloration™ platform is a proprietary microcapillary platform that screens the specificity and bioactivity of individual B cells, enhancing Ligand’s antibody discovery throughput and efficiency.